Ispecimen Inc. · NASDAQ:ISPC
Ispecimen — Investor Presentation (November 2021)
28 slides from Ispecimen's investor presentation, Nov 4, 2021
Slide 1: Transforming Biospecimen Procurement
CONNECT. INNOVATE. November 2021 Investor Presentation TRANSFORMING BIOSPECIMEN PROCUREMENT An online marketplace for human biospecimens
Slide 2: Forward-looking statements
This presentation may contain forward - looking statements within the meaning of Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended . Such forward - looking statements are characterized by future or conditional verbs such as
Slide 3: Executive management team
Christopher Ianelli, MD PhD | Chief Executive Officer, President, and Director Dr . Ianelli has been serving as our Chief Executive Officer, President, and Director since founding iSpecimen in July 2009 . Dr . Ianelli served as Chief Executive Officer of Abkine Pharmaceuticals, Inc . Dr . Ianelli se
Slide 4: Investor Highlights
Investor Highlights 4 ~200 Healthcare Provider / Supplier Organizations ~400 Customer Organizations 1. Early - stage opportunity with a first mover advantage 2. $3B - $4B global biospecimen market growing at 10 - 15% per year 1 3. Unique two - sided marketplace disrupting the biospecimen procurement
Slide 5: Our Vision
Accelerate scientific discovery in an online marketplace that empowers researchers to instantly search for and gain access to patients, biospecimens, and data across a global network of healthcare providers Our Vision 5
Slide 6: Human Biospecimens are Essential for Life Science R&D
Human Biospecimens are Essential for Life Science R&D Basic Research Biomarker Identification & Validation Drug Discovery & Development Diagnostics Discovery & Validation Biofluids Solid Tissue Stem & Immune Cells Plasma, Serum, Urine, Saliva Industry Academia Government 6 Lung, Breast, Colon, Brain
Slide 7: Large and Inefficient Biospecimen Market
10 - 15% Annual Growth Fueled by precision and regenerative medicine research 2 Disconnected Market Participants in Need of a Marketplace Solution With an Inefficient Supply Chain Manual processes plus fragmentation make it ripe for an online marketplace solution Large and Inefficient Biospecimen Ma
Slide 8: Market Inefficiencies
Market Inefficiencies PROVIDER RESEARCHER Scientist / Informaticist Procurem ent Legal & Compliance IT / Informaticist Scientist & Informaticist Legal & Compliance IT / Informaticist Researcher & Procurement Legal & Compliance Principal Investigator & Specimen Operations PATIENTS PROVIDERS RESEARCHE
Slide 9: Inefficiencies Lead to Losses
Inefficiencies Lead to Losses Providers miss revenue and research opportunities > 3 Billion clinical specimens are discarded annually worldwide 5 > 1 Billion Patient encounters yearly in the U.S. where a specimen could be provided for research 4 > 800 Million banked specimens are in biorepository in
Slide 10: The iSpecimen Marketplace Solution
The iSpecimen Marketplace Solution 10 PROVIDER Procurement Principal Investigator / Operations IT / Informaticist PATIENTS Legal & Compliance IT / Informaticist Researcher & Procurement Legal & Compliance Principal Investigator & Specimen Operations Scientist & Informaticist Blood / Pheresi s Center
Slide 11: Full-Service Procurement
Full - Service Procurement We Not Only Connect Suppliers and Customers, but We Also Manage the Entire Procurement Process Click to See the Overview Video SPECIMEN SEARCH & SELECTION SPECIMEN LOGISTICS SPECIMEN MANAGEMENT DATA MANAGEMENT STUDY/ORDER MANAGEMENT SUPPLIER SITE TRAINING COLLECTION KIT BU
Slide 12: Suppliers and Researchers Benefit
Suppliers and Researchers Benefit Advance Discovery Suppor t research mission and advance diagnostic, therapeutic, and vaccine research Increase Revenue Instantly connect to a global network of researchers Ensure Compliance On a platform that protects the privacy and security of patient information
Slide 13: Growing Supplier Adoption
13 34 66 102 147 181 197 2015 2016 2017 2018 2019 2020 September 30, 2021 Growing Supplier Adoption 1000+ Hospitals Also includes three Healthcare Information Exchanges 60% CAGR Number of Suppliers (2015 - Sept. 30, 2021) WORLDWIDE COVERAGE United States United Kingdom Germany France Ukraine Georg
Slide 14: Growing Researcher Adoption
$700 $1,448 $3,067 $4,395 $4,298 $8,184 $8,586 2015 2016 2017 2018 2019 2020 September 30, 2021 Cumulative Customer Organizations with Purchases 2015 – September 30, 2021 63% CAGR Customers (2015 - Sept. 30, 2021) Revenue ($000) - Unaudited 2015 - 18 2015 – September 30, 2021 63% CAGR Revenue (2
Slide 15: Growing Marketplace Adoption
80 118 668 1,587 2,681 3,871 4,878 2015 2016 2017 2018 2019 2020 September 30, 2021 Cumulative Researcher and Supplier Marketplace Users 2015 – September 30, 2021 104% CAGR Registered Users (2015 - Sept. 30, 2020) Growing Marketplace Adoption ~3,300 Unique searches performed by researchers in the
Slide 16: Growing Data Asset
“Utilization of sample data for research and for monetization is the next key value driver for the biobanks.” - Frost & Sullivan, Global Biobanking Market Landscape Growing Data Asset Banked Specimen Records Patient Records Medical Condition Records Clinical Specimen Records Laboratory Test Records
Slide 17: Statements of Operations (Unaudited)
Statements of Operations (Unaudited) 17 $ 2.3 M $ 2.7 M 3M 9/30/20 3M 9/30/21 Revenue (3Q20 vs. 3Q21) 21 % $ 5.5 M $ 8.6 M 9M 9/30/20 9M 9/30/21 Revenue (YTD20 vs. YTD21 ) 57 %
Slide 18: Balance Sheet
Balance Sheet Asof ‘As of December ‘September 30, 34,2020 2021 (audited) Assets Cash Ss 9790732 $ 695,909 ‘Accounts receivable - unbiled 4,750,744 652,761 ‘Accounts recewvable, net 2718882 1,526,382 Prepaid expenses and other current assets ‘459,321 ‘4178929 ‘Tax credt receivable, current porton 179
Slide 19: Fully Diluted Shares of Common Stock Outstanding
19 Fully Diluted Shares of Common Stock Outstanding
Slide 20: Investor Summary
Investor Summary 20 ~200 Healthcare Provider / Supplier Organizations ~400 Customer Organizations 1. Early - stage opportunity with a first mover advantage 2. $3B - $4B global biospecimen market growing at 10 - 15% per year 3. Unique two - sided marketplace disrupting the biospecimen procurement pro
Slide 21: Contact Us
CONNECT. INNOVATE. Sign up for free iSpecimen Marketplace account at www.ispecimen.com CONTACT US iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 investors@ispecimen.com ispecimen.com
Slide 22: Appendix
Appendix 22
Slide 23: Strategic Evolution
Strategic Evolution PHASE 3 Expansion via the Online iSpecimen Marketplace Ƞ START UP Company Ideation and Self - Funding PHASE 1 Proof of Concept PHASE 2 Critical Mass of Suppliers and Early Customer Adoption 2010 – 2011 2012 – 2013 2014 – 2017 2018 – September 30, 2021 0 Customers 1 Supplier A
Slide 24: iSpecimen Marketplace UI/UX: Tissue Search Example
iSpecimen Marketplace UI/UX Use Pulldowns to Enter Three High Level Search Criteria Tissue Search Example 24
Slide 25: iSpecimen Marketplace UI/UX: View Initial Results
to View Initial Results View Case Cards to See Specimens that Meet Criteria 25 iSpecimen Marketplace UI/UX
Slide 26: iSpecimen Marketplace UI/UX: Refine Search Results
Refine Search Results Using Sliders and Check Boxes Add Specimens to the Cart iSpecimen Marketplace UI/UX 26
Slide 27: iSpecimen Marketplace UI/UX: View Cart and Request a Quote
View Cart and Add More Specimens Request a Quote iSpecimen Marketplace UI/UX 27 Track and Manage Requests
Slide 28: Sources Cited
28 Page Note Source Cited 7 1 iSpecimen estimates based on In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics) By End - use, By Region, And Segment Forecasts, 2021 – 2027. Grandview Research, January 2021